Discontinuation and Switching of Therapy After Initiation of Lipid-Lowering Drugs: The Effects of Comorbidities and Patient Characteristics

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1046/j.1365-2125.2003.01818.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Lipid-Lowering Drugs (Statins) and Peripheral Neuropathy

Electronic Physician
2018English

Use of Antiepileptic Drugs and Lipid-Lowering Agents in the United States

Epilepsy and Behavior
NeurologyBehavioral Neuroscience
2014English

Controversial Issues of Pathogenesis and Lipid-Lowering Therapy of Atherosclerosis

Clinical pharmacology and therapy
2019English

Lipid Lowering Therapy and Circulating PCSK9 Concentration

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2017English

Three-Year Dynamics and Unsolved Problems of Lipid-Lowering Therapy

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2015English

The Effects of Lipid-Lowering Therapy on Graft Patency in Coronary Bypass Surgery Patients

Heart Surgery Forum
SurgeryCardiovascular MedicineCardiology
2006English

Paraneoplastic Hyperleucocytosis in a Melanoma Patient After Initiation of Ipilimumab and Nivolumab Combination Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Lipid Lowering Drugs and Inflammatory Changes: An Impact on Cardiovascular Outcomes?

Annals of Medicine
Medicine
2018English

Functional Evaluation of Lipid-Lowering Therapy by Pravastatin Response

Circulation
Cardiovascular MedicinePhysiologyCardiology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy